Valeant Pharmaceuticals International Inc (NYSE:VRX)

200.95
BATS BZX Real-Time Price
As of 10:59am ET
 +3.47 / +1.75%
Today’s Change
106.00
Today|||52-Week Range
204.66
+40.41%
Year-to-Date

Today’s Trading

Previous close197.48
Today’s open197.51
Day’s range197.19 - 200.57
Volume1,052,550
Average volume (3 months)2,624,594
Market cap$65.9B
Dividend yield--
Data as of 10:44am ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+25.40%
Earnings growth (next 5 years)+25.10%
Revenue growth (last year)+43.22%
P/E ratio--
Price/Sales5.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+2.06+0.89%
ABTAbbott Laboratories+0.10+0.21%
LLYEli Lilly and Co+0.42+0.60%
ACTActavis+4.44+1.52%
Data as of 10:59am ET, 03/02/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$2.31
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account